PFE - PFIZER INC

26.62
0.040   0.150%

Share volume: 30,790,196
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%
$26.58
0.04
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
36%
Profitability 49%
Dept financing 16%
Liquidity 33%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-2.35%
1 Month
0.49%
3 Months
2.27%
6 Months
6.99%
1 Year
2.62%
2 Year
2.07%
Key data
Stock price
$26.62
P/E Ratio 
17.92
DAY RANGE
$26.35 - $26.78
EPS 
$1.37
52 WEEK RANGE
$20.92 - $27.94
52 WEEK CHANGE
$1.45
MARKET CAP 
139.242 B
YIELD 
7.02%
SHARES OUTSTANDING 
5.686 B
DIVIDEND
$0.43
EX-DIVIDEND DATE
11-07-2025
NEXT EARNINGS DATE
07-29-2025
BETA 
0.06
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$35,939,802
AVERAGE 30 VOLUME 
$45,637,845
Company detail
CEO: Albert Bourla
Region: US
Website: pfizer.com
Employees: 83,000
IPO year: 1972
Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health. The company also provides biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Cibinqo brands.

Recent news